Cargando…
Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for unresectable hepatocellular carcinoma (HCC). Whether its efficacy is comparable to radiofrequency ablation (RFA), a recommended therapy for unresectable HCC, is unknown. The present study aims to compare the clinical outcome...
Autores principales: | Ji, Ren, Ng, Kelvin K., Chen, Wenqi, Yang, Weihong, Zhu, Hongtao, Cheung, Tan-To, Chiang, Chi-Leung, Wong, Tiffany C.L., Kong, Feng-Ming, Wu, G., Lo, Chung-Mau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797553/ https://www.ncbi.nlm.nih.gov/pubmed/35089192 http://dx.doi.org/10.1097/MD.0000000000028545 |
Ejemplares similares
-
Microwave ablation versus radiofrequency ablation for treating spinal metastases
por: Yao, Yuming, et al.
Publicado: (2023) -
Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 cm or Larger
por: Ke, Shan, et al.
Publicado: (2016) -
Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016) -
Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative: Two Case Reports
por: Gao, Jun, et al.
Publicado: (2015) -
Evaluation of the prognostic value of derived neutrophil/lymphocyte ratio in early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)